https://orcid.org/0000-0002-4730-4314
References
- Musselman ME, Saely S. Diagnosis and treatment of drug-induced hyperthermia. Am J Health Syst Pharm. 2013;70(1):34–42.
- Gowing LR, Henry-Edwards SM, Irvine RJ, et al. The health effects of ecstasy: a literature review. Drug Alcohol Rev. 2002;21(1):53–63.
- Rosenberg J, Pentel P, Pond S, et al. Hyperthermia associated with drug intoxication. Crit Care Med. 1986;14(11):964–969.
- Armenian P, Mamantov TM, Tsutaoka BT, et al. Multiple MDMA (ecstasy) overdoses at a rave event: a case series. J Intensive Care Med. 2013;28(4):252–258.
- Gummin DD, Mowry JB, Beuhler MC, et al. 2020 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021;59(12):1282–1501. doi:10.1080/15563650.2021.1989785
- Dawson AH, Buckley NA. Pharmacological management of anticholinergic delirium – theory, evidence and practice. Br J Clin Pharmacol. 2016;81(3):516–524.
- von Elm E, Altman DG, Egger M, STROBE Initiative, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457.
- Wang GS, Baker K, Ng P, et al. A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome. Clin Toxicol. 2021;59(8):698–704.
- Hughes AR, Lin A, Hendrickson RG. Oct on Behalf of Toxicology Investigator’s Consortium (ToxIC)ToxIC) TIsC. Clinical and patient characteristics associated with severe outcome in diphenhydramine toxicity. Clin Toxicol. 2021;59(10):918–925.
- Laskowski LK, Landry A, Vassallo SU, et al. Ice water submersion for rapid cooling in severe drug-induced hyperthermia. Clin Toxicol. 2015;53(3):181–184.